Baxter recalls saline bags after fibreglass found

Negative4 min readAI-generated summary

Report this article

Tell us what is wrong. We read every report.

Report this article
Baxter recalls saline bags after fibreglass found
Health

International Business Times UK

Baxter announced a voluntary nationwide recall on 25 August 2026 after fibreglass particulate matter was found inside sealed 500 mL VIAFLEX 0.9% sodium chloride injection bags from product code 2B1323Q, lots Y495523 and Y495523A (expiry 31 October 2027, NDC 0338-0049-03). Shipments went to hospitals and distributors across 14 US states between 31 July and 3 August 2026. The FDA posted the recall notice and warned of potential clotting, organ damage and death; Baxter said it had received no adverse event reports as of the announcement and instructed immediate discontinuation and return of affected units.

Two lots of IV saline were recalled for fibreglass contamination.

Context

Fibreglass was found inside the saline solution in two lots. Baxter notified the FDA and initiated a voluntary recall. Hospitals will isolate and return units while the FDA monitors for reports.

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

  • Full ContextLocked
  • Affected SectorsLocked
  • Stock ImpactLocked
  • Economic IndicatorLocked
  • Investor RelevanceLocked
  • Professional RelevanceLocked
  • Watch PointsLocked
  • Probability of ChangeLocked
  • Debate PointsLocked
  • Historical ParallelLocked
  • Follow-up QuestionsLocked
  • Pros & ConsLocked
Read free — no credit card